Zomedica Corp. (ZOMDF)
0.0789
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Zomedica Enterprise Value : 34.99M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 34.99M |
| October 01, 2026 | 34.53M |
| September 30, 2026 | 36.09M |
| September 29, 2026 | 33.69M |
| September 28, 2026 | 36.08M |
| September 25, 2026 | 36.09M |
| September 24, 2026 | 29.72M |
| September 23, 2026 | 33.94M |
| September 22, 2026 | 30.41M |
| September 21, 2026 | 35.09M |
| September 18, 2026 | 33.51M |
| September 17, 2026 | 37.07M |
| September 16, 2026 | 36.96M |
| September 15, 2026 | 39.91M |
| September 14, 2026 | 40.80M |
| September 11, 2026 | 39.20M |
| September 10, 2026 | 39.91M |
| September 09, 2026 | 38.85M |
| September 08, 2026 | 41.97M |
| September 04, 2026 | 40.89M |
| September 03, 2026 | 40.40M |
| September 02, 2026 | 40.99M |
| September 01, 2026 | 40.60M |
| August 31, 2026 | 41.97M |
| August 28, 2026 | 38.05M |
| Date | Value |
|---|---|
| August 27, 2026 | 40.99M |
| August 26, 2026 | 41.78M |
| August 25, 2026 | 41.97M |
| August 24, 2026 | 41.97M |
| August 21, 2026 | 41.87M |
| August 20, 2026 | 41.87M |
| August 19, 2026 | 40.65M |
| August 18, 2026 | 40.99M |
| August 17, 2026 | 38.05M |
| August 14, 2026 | 41.97M |
| August 13, 2026 | 43.93M |
| August 12, 2026 | 44.62M |
| August 11, 2026 | 45.21M |
| August 10, 2026 | 39.37M |
| August 07, 2026 | 39.52M |
| August 06, 2026 | 43.64M |
| August 05, 2026 | 45.89M |
| August 04, 2026 | 41.97M |
| August 03, 2026 | 44.91M |
| July 31, 2026 | 45.89M |
| July 30, 2026 | 43.93M |
| July 29, 2026 | 39.03M |
| July 28, 2026 | 39.95M |
| July 27, 2026 | 44.81M |
| July 24, 2026 | 43.15M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Biomerica, Inc. | 7.919M |
| Univec, Inc. | 6.020M |
| Lantheus Holdings, Inc. | 6.556B |
| IDEXX Laboratories, Inc. | 41.79B |
| Neogen Corp. | 3.272B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.765M |
| Revenue (Quarterly) | 9.512M |
| Total Expenses (Quarterly) | 13.28M |
| EPS Diluted (Quarterly) | -0.0038 |
| Gross Profit Margin (Quarterly) | 63.51% |
| Profit Margin (Quarterly) | -39.58% |
| Earnings Yield | -24.34% |
| Normalized Earnings Yield | -24.47 |